| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |